This message is from the Neuroendocrine Research Foundation.
The coronavirus disease (COVID-19) outbreak concerns everyone in the NET community. Issues range from reducing exposure to the disease to getting basic supplies. NETRF encourages patients and families to seek information and guidance from the U.S. Centers for Disease Control, the World Health Organization, as well as regional health authorities.
NETRF will offer NET-specific updates as information becomes available. We’ve compiled information on reducing the risk of COVID-19 as well as coping with social distancing and isolation.
Thanks to NETRF Board member and NORCAL CarciNET president Josh Mailman for recently posting a Q&A with Pamela Kunz, MD, NET specialist, and Janice Brown, MD, infectious disease specialist, Stanford Unversity, to address NET patients’ common concerns.
NETRF Board member Dr. Mark Lewis, a NET patient and oncologist at Intermountain Health, shares his thoughts in this interview.
My thanks to the Neuroendocrine Research Foundation.
May we all have the best possible outcomes,